The-hydroxy/amino acid unit is a common structural feature of many bioactive marine cyanobacterial depsipeptides. In this study, the absolute stereochemistry of the -hydroxy acid moieties in hantupeptins and trungapeptins were determined through their synthesis and HPLC analysis of the Mosher ester derivatives. Synthesis of two3-hydroxy-2-methyloctanoic acid (Hmoa) stereoisomers, (2S,3R)-Hmoa and (2S,3S)-Hmoa, were achieved using diastereoselective asymmetric method and the retention times of all four Hmoa isomers were established indirectly by RPLC-MS analysis of their Mosher ester derivative standards. Based on the retention times of the standards, the absolute configuration of the Hmoa unit in hantupeptin C (3) and trungapeptin C (6) was assigned as (2R,3S)-and (2S,3R)-Hmoa, respectively. The use of the Mosher's reagents, coupled with HPLC analysis, provided a viable alternative to the absolute stereochemical determination of -hydroxy acid units in depsipeptides.
Marine cyanobacteria are a rich source of novel bioactive natural products for drug discovery and development [1] . Hantupeptins (1-3) and trungapeptins (4) (5) (6) are cyclic depsipeptides recently isolated from the marine cyanobacterium, Lyngbya majuscula (Figure 1 ) [2] [3] [4] . Hantupeptins, in particular, were reported to exhibit significant in vitro anticancer activity [2, 3] . The structures of these cyclic depsipeptides are characterized by the presence of -hydroxy acid units, occurring as a 3-hydroxy-2-methyl-octynoic acid (Hmoya), 3hydroxy-2-methyl-octenoic acid (Hmoea), or 3-hydroxy-2-methyloctanoic acid (Hmoa) moiety [2] [3] [4] .
Other marine-derived metabolites, such as viequeamide A [5] , kulomo'opunalides [6] , veraguamides [7, 8] , and onchidin B [9] , have been reported to contain structurally related -hydroxy acid units. In our ongoing efforts toward the total synthesis of the hantupeptins, confirmation of the absolute stereochemistry of the -hydroxy acid units is important. Herein, we report the use of the (R)-and (S)-Mosher's reagents as chiral derivatizing agents for the absolute stereochemical determination of the Hmoa unit present in hantupeptin C (3) and trungapeptin C (6) [10] .
To determine the stereochemistry of the Hmoa unit in 3, the synthesis of two stereoisomers of Hmoa, (2S,3R)-Hmoa (9) and (2S,3S)-Hmoa (14) , using a diastereoselective method was initiated [11] [12] [13] . Briefly, Evans reaction involving Evans auxiliary, (S)-4benzyl-3-propionyloxazolidin-2-one (7) , afforded (S)-4-benzyl-3-[(2S,3R)-3-hydroxy-2-methyloctanoyl]oxazolidin-2-one (8) having temporary installation of chiral auxiliary fragments of known absolute configuration. Compound 8 was then cleaved to obtain enantiomerically pure (2S,3R)-Hmoa (9) [14, 15] . Mitsunobu reaction on 8, which allows the inversion of configuration at the hydroxylated carbon C-3, yielded the other isomer, (2S,3S)-Hmoa (14) [16] . Each of the two synthesized stereoisomers of Hmoa underwent Fisher esterification to obtain methyl esterified derivatives, (2S,3R)-methyl-3-hydroxy-2-methyloctanoate (10) and (2S,3S)-methyl-3-hydroxy-2-methyloctanoate (15) . Subsequently, the two synthesized methyl esters of Hmoa, 10 and 15, were derivatized separately with either (R)-or (S)-Mosher's acid chloride to provide four synthetic diastereomers of 11, 12, 16, and 17 having stereochemistry of (2S,3R,2'S), (2S,3R,2'R), (2S,3S,2'S), and (2S,3S,2'R), respectively (Scheme 1).
Evans oxazolidinone-containing molecule, 8 (2.5 g, 87.6% yield), was formed from a syn addition of n-hexanal with 7 via a transition state involving a BBu 2 adduct, using (nBu) 2 BOTf (dibutylborontriflate) as the chelating agent that favored the Z enolate configuration (Scheme 2). That the R configuration of the hydroxyl group at C-3 in 8 was obtained as the desired configuration indicated that there was no significant dipolar repulsion between the enolate C-O and oxazolidinone C=O in the transition state. This enhanced the stability of the transition state, which favored the formation of the desired product 8.
Compound 9 (0.17 g, 66.8% yield) was obtained by removing the Evans auxiliary using H 2 O 2 and then reducing the peracid intermediate with Na 2 SO 3 (Scheme 1). The addition of LiOH with H 2 O 2 produced LiOOH, which ensured cleavage of the auxiliary and yielded the free (2S,3R)-Hmoa (9) [11] . No purification of 9 was required as the removal of the auxiliary was complete based on 1 H NMR spectral data. In order to prepare compound 14, (2S,3S)-Hmoa, the stereochemistry at C-3 in 8 was inverted from R to S through the use of Mitsunobu reaction (Scheme 1). During the reaction, we faced the challenge of obtaining the purified product, 13, due to the presence of the triphenylphosphine reagent. The yield of compound 13 (0.43 g, 74.3% yield) was eventually improved by the use of resin-bound triphenylphosphine. Simultaneous hydrolysis of the benzoate ester moiety and Evans auxiliary in 13 was achieved through a combination of H 2 O 2 , followed by Na 2 SO 3, to yield (2S,3S)-Hmoa, 14 (0.13 g, 85.9% yield). The two synthetic isomers of Hmoa with configurations (2S,3R) and (2S,3S) in 9 and 14, respectively were synthesized.
In order to obtain distinct retention times of compounds 9 and 14 on RP-HPLC, their methyl-ester derivatives were analysized. Fisher esterification of compounds 9 and 14 in MeOH yielded (2S,3R)methyl-3-hydroxy-2-methyloctanoate (10, 0.11 g, 65.6%) and (2S,3S)-methyl-3-hydroxy-2-methyloctanoate (15, 0.11 g, 60.1%), respectively, in substantial yields (> 80%) (Scheme 1).
The methyl esters of Hmoa were then derivatized with either (R)-or (S)-MTPA-Cl [-methoxy--(trifluroromethyl)phenylacetyl chloride] to provide (2S,3R,2'S) 11 or (2S,3R,2'R) 12, respectively In conclusion, the absolute stereochemistry of the Hmoa units in hantupeptin C (3) and trungapeptin C (6) were determined as (2R,3S)-and (2S,3R)-Hmoa, respectively. This is consistent with the stereochemistry previously reported in the literature [2] [3] [4] . In addition, this study demonstrated that chiral Mosher's reagents coupled with RP-HPLC analysis can be adapted for the absolute stereochemical determination of -hydroxy acid units in natural products.
Experimental
General: 1 H and 13 C NMR spectra were recorded on a 400 MHz Bruker NMR spectrometer in CDCl 3 (Cambridge Isotope Laboratories, Inc.), 99.8% D containing 0.03%, v/v, tetramethylsilane (TMS) and residual solvent signal (δ H at 7.26 ppm and δ C at 77.36 ppm) as internal standard. A linear gradient method, used for LCMS data to confirm the absolute stereochemical analysis of the hydrolysate, was carried out with a C 18 RP-HPLC column [Phenomenex Sphereclone 5 µm C 18 (2) 100 Å, 150 x 2.00 mm] using an Agilent 1100 series LC system coupled to a mass selective detector (MSD) ion trap XCT mass spectrometer equipped with an ESI interface system. TLC was performed using silica gel 60, F 254 (green fluorescence) pre-coated glass plates with a thickness of 250 μm and a mean particle size of 10-12 μm (Merck). All solvents were HPLC grade (Sigma-Aldrich), and water was purified by a Millipore Milli-Q system before use.
Preparation of (S)-4-benzyl-3-[(2S,3R)-3-hydroxy-2methyloctanoyl]oxazolidin-2-one (8):
A stirred solution of (S)-4benzyl-3-propionyloxazolidin-2-one (7) (2.0 g, 8.57 mmol) in dry CH 2 Cl 2 (20.0 mL) was cooled to 0 o C and sequentially treated dropwise via a syringe with 1.0 M dibutyl boron triflate (12 mL, 12 mmol in CH 2 Cl 2 ) and triethylamine (2.0 mL, 14.35 mmol). The resulting solution was cooled to -40 o C, and a solution of hexanal (1.5 mL) was added dropwise via a syringe. The resulting mixture was stirred at -40 o C for 20 min and then an additional hour at 0 o C. The reaction was quenched by addition of aqueous phosphate buffered solution (pH 7.0, 10.0 mL) and CH 3 OH (10.0 mL). Then a mixture of CH 3 OH:30% H 2 O 2 (2:1, 13.3 mL) was added, and the resulting solution was stirred for 45 min at rt. The solvent was evaporated under reduced pressure, the residue redissolved in water (26.6 ml), and the resulting solution extracted with EtOAc (3 × 13.3 mL). The combined organic phase was washed with 5% NaHCO 3 (26.6 mL) and brine (26.6 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure, yielding a viscous colorless liquid. The crude was purified by flash chromatography using EtOAc:hexane (1:3) to provide 8. 
(S)-4-Benzyl-3-[(2S,3R)-3-hydroxy-2-methyloctanoyl]oxazolidin-2-one (8)

Preparation of (2S,3R)-3-hydroxy-2-methyloctanoic acid (9):
A solution of 8 (0.5 g, 1.5 mmol) in THF:H 2 O (4:1, 7.5 mL) was cooled to 0 o C. To this solution was added 30% H 2 O 2 (0.6 mL, 6.0 mmol) and a solution of LiOH (58.5 mg, 6.0 mmol) in H 2 O (3.0 mL). The solution was stirred continuously for 1 h. After that, a solution of Na 2 SO 3 (0.75 g, 5.95 mmol) in water (4.5 mL) was added, and the resulting solution was stirred for another 15 min. The organic solvent was concentrated under reduced pressure, and the resulting aqueous phase (~pH 12.0) was extracted with CH 2 Cl 2 (3 × 9.0 mL). Then, the aqueous phase was cooled to 0 o C, acidified to pH 1.0 with 6 N HCl, and extracted with EtOAc (5 × 6.0 mL). The organic phase was dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure to yield the white solid compound 9.
Preparation of (2S,3S)-1-[(S)-4-benzyl-2-oxooxazolidin-3-yl]-2methyl-1-oxooctan-3-yl-4-nitrobenzoate (13):
A solution of diethylazodicarboxylate (1.46 g, 8.4 mmol) in benzene (5.0mL) was added to 8 (0.40 g, 1.2 mmol), triphenylphosphine (2.2 g, 8.4 mmol), and p-nitrobenzoicacid (1.40 g, 8.4 mmol) in benzene (40.0mL) at rt. The resulting solution was stirred for 17 h at rt. The solvent was removed under reduced pressure, and the reaction crude was purified by flash chromatography using EtOAc: hexane (1:7) , yielding the nitrobenzoate ester 13 as a yellow viscous liquid. (2S,3S)-3-hydroxy-2-methyloctanoic acid (14) : A solution of 13 (0.4 g, 0.89 mmol), cooled to 0 o C, in THF:H 2 O (4:1, 41.4 mL) was sequentially treated with 30% H 2 O 2 (0.4 mL, 3.92 mmol), followed by a solution of LiOH (71.0 mg, 2.97 mmol) in H 2 O (1.7mL). The mixture was stirred for 1 h at 0 o C and then for a period of 18 h at rt. Aqueous Na 2 SO 3 (0.5 g, 3.97 mmol) in H 2 O (2.6 mL) was added, and the organic solvent was removed under reduced pressure. The resulting aqueous phase was extracted with CH 2 Cl 2 (4 × 5.3 mL), acidified to pH 1.0 with 6 N HCl and reextracted with EtOAc (4 × 3.5 mL). The combined EtOAc extract was washed with brine (51.7 mL), dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure to yield a colorless viscous liquid 14.
Preparation of
Preparation of(2S,3R)-methyl-3-hydroxy-2-methyloctanoate (10) and (2S,3S)-methyl-3-hydroxy-2-methyloctanoate (15):
Samples of 9 (0.15 g, 0.85 mmol) and 14 (0.18 g, 1.0 mmol) were dissolved separately in CH 3 OH (20.8 g, 0.2 mol; 24.7 g, 0.37 mol) with a few boiling chips. Each mixture was heated under reflux with a few drops of concentrated H 2 SO 4 for 1 h. The solution was then cooled in an ice bath, decanted into 25.0 mL of H 2 O, and extracted with EtOAc (3 × 5.0 mL). The combined organic phase was washed with 2.0 M Na 2 CO 3 (10.0 mL), dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure to yield the methyl esters 10 and 15 as a colorless viscous liquid and yellow viscous liquid, respectively. (11, 12, 16, and 17) : Each portion of 10 and 15 in dry CH 2 Cl 2 (4.0 mL) was divided into two equal portions, and small amounts of DMAP (4-dimethylaminopyridine) were added to each divided portion. Each portion was then treated with small amounts of (R)-MTPA-Cl and (S)-MTPA-Cl [methoxy--(trifluroromethyl) phenylacetyl chloride] separately and stirred for 12 h at rt, to yield the (2S,3R) ester with S and R configuration at C-2' in (2S,3R,2'S) 11 and (2S,3R,2'R) 12, respectively. Similarly in the (2S,3S) ester with S and R configuration at C-2' in (2S,3S,2'S) 16 and (2S,3S,2'R) 17, respectively. 
Preparation of 2-methyl-3-[(3,3,3-trifluoro-2-methoxy-2phenylpropanoyl)oxy]octanoate
Preparation of Mosher methyl ester derivative of Hmoa in hantupeptin C:
Reduction of trungapeptin A and preparation of Mosher methyl ester derivative of Hmoa in trungapeptin C:
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determined through trungapeptin A (4).
Compound 4 was hydrogenated with 10% Pd/C (palladium on carbon) to fully reduce the terminal alkyne functionality as in 6. A stirred solution containing 1.0 mg of trungapeptin A (4) in 2.0 mL of EtOH was treated with 1.3 mg of 10% Pd/C, and the atmosphere was replaced with H 2 (g) by balloons pressure. The reaction mixture was stirred at rt for 3 h and filtered through glass wool into a reaction vial with 10.0 mL of CH 2 Cl 2 . The sample was then concentrated under reduced pressure in vacuo and finally dried under a stream of N 2 (g). The hydrogenated solid residues were hydrolyzed in 6N HCl at 110 o C for 12 h to yield the β-hydroxy acid equivalent to the unit of trungapeptin C (6), which then underwent Fisher esterification and subsequent derivatization with (R)-MTPA-Cl to obtain the Mosher derivatized natural Hmoa unit for direct comparision of t R with the established stereochemistry of hantupeptin C (3).
Absolute stereochemical analysis of Hmoa in hantupeptin C and trungapeptin C:
The Mosher ester derivatives, (2S,3R,2'S) 11, (2S,3R,2'R) 12, (2S,3S,2'S) 16, (2S,3S,2'R) 17, and the Mosher derivatized natural Hmoa from the acid hydrolysis of hantupeptin C (3), were analyzed using RPLC-MS (linear gradient of H 2 O:ACN; 80:20 to 0:100 in 45 min at 0.4 mL/min) with the mass detector in negative mode fixed at m/z 403. Four distinct peaks with t R of 17.57 min, 10.15 min, 10.20 min, and 12.70 min were obtained for 11, 12, 16, and 17, respectively. Co-injections of the standards with the Mosher derivatized Hmoa from 3 (t R at 10.15 min) confirmed the stereochemistry of (2R,3S)-Hmoa in hantupeptin C. Similar analysis were conducted on the Mosher derivatized Hmoa from trungapeptin C (t R at 17.57 min) and the stereochemistry of (2S,3R)-Hmoa in 6 was confirmed [17] .
